Advertisement
UK markets closed
  • FTSE 100

    8,203.93
    -37.33 (-0.45%)
     
  • FTSE 250

    20,786.65
    +176.31 (+0.86%)
     
  • AIM

    774.39
    +4.97 (+0.65%)
     
  • GBP/EUR

    1.1819
    +0.0021 (+0.18%)
     
  • GBP/USD

    1.2813
    +0.0052 (+0.41%)
     
  • Bitcoin GBP

    45,112.97
    +971.52 (+2.20%)
     
  • CMC Crypto 200

    1,202.40
    -6.30 (-0.52%)
     
  • S&P 500

    5,567.19
    +30.17 (+0.54%)
     
  • DOW

    39,375.87
    +67.87 (+0.17%)
     
  • CRUDE OIL

    83.44
    -0.44 (-0.52%)
     
  • GOLD FUTURES

    2,399.80
    +30.40 (+1.28%)
     
  • NIKKEI 225

    40,912.37
    -1.28 (-0.00%)
     
  • HANG SENG

    17,799.61
    -228.67 (-1.27%)
     
  • DAX

    18,475.45
    +24.97 (+0.14%)
     
  • CAC 40

    7,675.62
    -20.16 (-0.26%)
     

Artisan Investments raises stake in Philips to 10%, regulatory filing shows

Philips Healthcare headquarters is seen in Best

AMSTERDAM (Reuters) - U.S. asset management firm Artisan Investments has raised its stake in Philips to 10%, sending the healthcare technology group's shares rising on Wednesday, a week after the Dutch company's biggest shareholder also increased its holding.

At 1045 GMT, Philips shares were up 1.66% at 23.90 euros, outperforming the Dutch stock market blue-chip AEX (+1.05%) as well as the Stoxx Europe 600 healthcare index (-0.1%).

After raising its stake, Artisan Investments now owns 94.13 million shares in Philips, or about 10% of the company, according to a regulatory filing published earlier.

"Artisan has owned more than 9% in Philips for quite some time and has recently increased their stake to 10% after (our) Q1 results. We see this as a signal of trust in our strategy and plan," a Philips spokesperson told Reuters.

ADVERTISEMENT

Artisan Investments is now Philips' second-largest shareholder behind Exor, the investment arm of Italy's Agnelli family, which increased its stake to 17.51% last week.

Philips reported a better-than-expected first-quarter profit on April 29, with its adjusted earnings before interest, taxes and amortisation (EBITA) jumping 8% to 388 million euros ($417.22 million).

The company also announced a smaller-than-expected settlement on the same day to resolve claims over recalled breathing devices in the U.S.

($1 = 0.9300 euros)

(Reporting by Toby Sterling and Benoit Van Overstraeten; Editing by Louise Heavens and Anil D'Silva)